Skip Navigation
Skip to contents

KDDW 2025


Speakers

Home    >    Program    >    Speakers

Member Societies

검색
  • * Bookmark: To add speakers to your Favorites, log in and click 'Star.' Your Favorites List can be found on My Page.

Symposium 01: Distinguished papers of 2024–2025 in Clinical and Molecular Hepatology
Nov. 13 (Thu), 09:00-10:35

  • The CMH journey: Global growth and author guidance Yeonjung Ha
    CHA University, Korea
    즐겨찾기
  • CMH clinical research highlight–Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment Do Seon Song
    The Catholic University of Korea, Korea
    즐겨찾기
  • CMH clinical trial highlight–Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial Yao-Chun Hsu
    I-Shou University, Taiwan
    CV 즐겨찾기
  • CMH epidemiologic research highlight–Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study Jeong-Hoon Lee
    Seoul National University, Korea
    즐겨찾기
  • CMH multinational research highlight–Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306) Xiaolong Qi
    Southeast University, China
    즐겨찾기

Presidential Lecture: Chung Yong Kim memorial lecture
Nov. 13 (Thu), 10:50-11:20

  • The liver odyssey: Four decades of progression and hope Joong-Won Park
    Myongji Hospital, Korea
    CV 즐겨찾기

Symposium 09: Special considerations for liver diseases in distinct conditions
Nov. 13 (Thu), 13:20-14:50

  • Risk-stratified prophylaxis for HBV reactivation in patients receiving biological agents Pin-Nan Cheng
    National Cheng Kung University, Taiwan
    CV 즐겨찾기
  • Management of anti-HBc or HBsAg-positive donors and recipients in liver transplantation Deok Gie Kim
    Yonsei University, Korea
    즐겨찾기
  • Risks and benefits of statins and DOACs in cirrhotic patients with cardiovascular disease Ho Soo Chun
    Ewha Womans University, Korea
    CV 즐겨찾기
  • Current controversies in HCC risk and surveillance after SVR in HCV-infected patients Ryosuke Tateishi
    The University of Tokyo, Japan
    CV 즐겨찾기

Symposium 13: Big data in hepatology research: Sources and applications
Nov. 13 (Thu), 15:10-16:40

  • Korean nationwide population-based study using the National Health Information Database Han Ah Lee
    Chung-Ang University, Korea
    CV 즐겨찾기
  • Taiwanese nationwide database for chronic viral hepatitis Mei-Hsuan Lee
    National Yang Ming Chiao Tung University, Taiwan
    즐겨찾기
  • Common data models for real-world data analysis Rae Woong Park
    Ajou University, Korea
    CV 즐겨찾기
  • Hepatocellular carcinoma in the setting of alcohol-related liver disease: insights from French prospective cohort studies Pierre Nahon
    Université Sorbonne Paris Nord, France
    CV 즐겨찾기

Symposium 17: Optimizing treatment strategies for HCC: Concurrent and sequential approaches
Nov. 14 (Fri), 08:30-10:00

  • The priority decision for subsequent systemic therapy after first-line failure of ICI-based regimens for HCC Arndt Vogel
    University of Toronto, Canada
    CV 즐겨찾기
  • Promising systemic agents for combination therapy with TACE and their mechanistic rationales in incurable HCC Sung Won Chung
    University of Ulsan, Korea
    즐겨찾기
  • Role of radiotherapy for advanced-stage HCC in the era of IO Jeong Il Yu
    Sungkyunkwan University, Korea
    즐겨찾기
  • Efficacy and safety of ICI-based treatment for Child-Pugh B HCC Jean-Charles Nault
    Université Sorbonne Paris Nord, France
    CV 즐겨찾기

Symposium 22: In vitro and in vivo experimental models to study liver diseases
Nov. 14 (Fri), 10:20-11:50

  • Models for hepatitis B and the associated liver cancers Kyun-Hwan Kim
    Sungkyunkwan University, Korea
    CV 즐겨찾기
  • Preclinical MASH studies Sang Geon Kim
    Dongguk University, Korea
    CV 즐겨찾기
  • Cancer immunotherapy research Tae-Jin Kim
    Korea Institute of Radiological & Medical Sciences, Korea
    CV 즐겨찾기

Symposium 27: Biomarkers for diagnosis, treatment response, and prognosis in liver diseases
Nov. 14 (Fri), 13:20-14:50

  • Early predictors of hepatitis B relapse after antiviral cessation Cheng-Hao Tseng
    I-Shou University, Taiwan
    CV 즐겨찾기
  • Biomarkers for monitoring disease progression in MASLD Nobuharu Tamaki
    Musashino Red Cross Hospital, Japan
    CV 즐겨찾기
  • Imaging markers predicting response to IO in HCC Subin Heo
    University of Ulsan, Korea
    CV 즐겨찾기
  • Histological markers for differential diagnosis of liver tumors and inflammatory conditions Haeryoung Kim
    Seoul National University, Korea
    CV 즐겨찾기

PG Course 04: Guidelines and evidence-based recommendations in liver disease management
Nov. 14 (Fri), 15:10-16:40

  • Chronic hepatitis B: Antiviral strategy Won-Mook Choi
    University of Ulsan, Korea
    즐겨찾기
  • Chronic hepatitis C: Antiviral strategy Young Kul Jung
    Korea University, Korea
    즐겨찾기
  • MASLD: Current and potential new treatments Won Sohn
    Sungkyunkwan University, Korea
    CV 즐겨찾기
  • Liver cirrhosis: Complications and specific management Do Seon Song
    The Catholic University of Korea, Korea
    즐겨찾기

USG: Abdominal US training specialist 01
Nov. 15 (Sat), 08:30-10:00

  • Experiences and challenges in ultrasound education Tae Suk Kim
    Kangwon National University, Korea
    CV 즐겨찾기
  • Clinical practice guidelines for the managing pancreatic cystic neoplasm Yoonseok Lee
    Gachon University, Korea
    CV 즐겨찾기
  • CEUS LI-RADS for diagnosis of hepatocellular carcinoma Jae Seok Bae
    Seoul National University, Korea
    CV 즐겨찾기
  • Recent advances and future perspectives in spleen stiffness measurement Jeong-Ju Yoo
    Soonchunhyang University, Korea
    CV 즐겨찾기

USG: Abdominal US training beginner
Nov. 15 (Sat), 08:30-10:00

  • Scanning technique for the beginner: Liver Ji Won Park
    Hallym University, Korea
    CV 즐겨찾기
  • Scanning technique for the beginner: Pancreato-biliary Heechul Nam
    The Catholic University of Korea, Korea
    CV 즐겨찾기
  • Clinical approach for common abdominal US findings: Cystic liver disease & GB polyp Ji Eun Han
    Ajou University, Korea
    즐겨찾기

USG: Abdominal US training specialist 02
Nov. 15 (Sat), 10:20-11:50

  • Noninvasive assessment of hepatic steatosis in MASLD era Tae Seop Lim
    Yonsei University, Korea
    CV 즐겨찾기
  • Advancements and future directions in elastography for portal hypertension Young Chang
    Soonchunhyang University, Korea
    즐겨찾기
  • US guided percutaneous biopsy of abdominal viscera Jeong Woo Kim
    Korea University, Korea
    즐겨찾기
  • Future of AI and digital solutions in ultrasound Daehyoun Cho
    GE Healthcare, Korea
    즐겨찾기
-->
Supported by Member Societies
Associated Society
Supported by
Diamond
  • 대웅제약
Platinum
Gold
Silver
Bronze
  • 한미약품
  • 한국로슈
  • 다케다
  • 에브비
  • 부광약품
  • 노보노딕스

Go to Top

KDDW Consortium (케이디디더블유 운영협의체)

Business License No.: 609-82-84671

President: Joo-Sung Kim

E-mail : kddwoffice@gmail.com

Address : 2F, 30, Bamgogae-ro 1-gil, Gangnam-gu, Seoul, 06349, Republic of Korea
KDDW 2025 Secretariat
Contact (Scientific Program & Abstract)
Email. kddwinfo@medioffice.or.kr / Tel. +82-10-2334-8265
(Registration & Sponsor)
Email. kddwconference@medioffice.or.kr / Tel. +82-2-459-8266